| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Clinical Development | VP, Clinical Trial Operations
1 company
Yu Yong is a SVP, Clinical Development at Genelux Corporation. Recent SEC Form 4 filings include 1 buy and 12 sells.
Estimated insider holdings value: $451K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 24, 2026 | GNLX Genelux Corporation | SVP, Clinical Development | Sell | 906 | $2.42 | $2,192.52 | -0.6% | - | - | |
| Nov 17, 2025 | GNLX Genelux Corp | SVP, Clinical Development | Sell | 4,192 | $3.82 | $16,031.90 | -1.4% | -51.2% | - | |
| May 12, 2025 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sell | 5,579 | $2.92 | $16,290.68 | -10.5% | +18.0% | - | |
| Jun 24, 2024 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sell | 6,849 | $2.12 | $14,519.88 | -38.7% | -5.7% | +21.9% | |
| May 29, 2024 | GNLX Genelux Corp | VP, Clinical Trial Operations | Buy | 2,500 | $0.00 | - | New | -25.4% | -12.1% | |
| Dec 15, 2023 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sell | 32,535 | $13.16 | $428,179.82 | -84.9% | -51.5% | -81.9% | |
| Dec 7, 2023 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sell | 36,800 | $11.85 | $435,995.36 | -53.1% | -44.9% | -77.5% | |
| Nov 21, 2023 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sell | 18,665 | $10.26 | $191,555.16 | -21.2% | -28.3% | -76.0% | |
| Nov 20, 2023 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sell | 18,135 | $11.60 | $210,430.99 | -8.7% | -30.6% | -76.9% | |
| Oct 24, 2023 | GNLX Genelux Corp | VP, Clinical Trial Operations | Sale+OE | 5,200 | $19.11 | $99,351.20 | -4.7% | -40.8% | -87.4% |